This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Teicher, B. A. Articles by Frei, E. Search for Related Content PubMed PubMed Citation Articles by Teicher, B. A. Articles by Frei, E., III

Characterization of a Human Squamous Carcinoma Cell Line Resistant to cis-Diamminedichloroplatinum(II)¹

Division of Cancer Pharmacology, Dana-Farber Cancer Institute, Boston, MA 02115

We have developed a human head and neck squamous cell carcinoma cell line (SCC-25/CP) which is relatively stably resistant to cis-diamminedichloroplatinum(II) (CDDP) after repeated exposure to escalating doses of the drug. The studies reported elucidate the mechanism(s) by which the SCC-25/CP cell line is resistant to CDDP. The SCC-25/CP cell line is approximately 30-fold resistant to CDDP, approximately 10-fold resistant to carboplatin, and about 9-fold resistant to iproplatin.

Using [^195mPt]CDDP, we examined the levels of platinum in whole cells and cellular fractions of both the SCC-25 and SCC-25/CP cells after 1 h exposure to 100 µM drug. The SCC-25 cells took up 30 pmol of platinum/10⁶ cells in 1 h; 64% of the drug was in the nucleus and 21% in the cytosol. The SCC-25/CP cells took up 7 pmol of platinum/10⁶ cells; of this, 41% was in the nucleus and 33% in the cytosol. The SCC-25 cell nuclei contained 331 pmol of platinum/mg protein and the cytosol 21 pmol of platinum/mg protein, whereas the SCC-25/CP cell nuclei contained 47 pmol of platinum/mg protein and the cytosol 8.1 pmol/mg protein. The release of drug from both cell lines followed a very similar course and was most rapid over the first 6 h.

There was no difference in the non-protein sulfhydryl content of the cell lines. The protein sulfhydryl content, as measured by Ellman's procedure, indicated that the SCC-25/CP cell line has approximately a 2-fold increase in protein sulfhydryl content compared to the SCC-25 cell line. The SCC-25/CP cell line is about 2-fold resistant to cadmium chloride at 50% cell kill and about 2.5-fold resistant at 1 log kill compared to the SCC-25 cell line. Glutathione transferase activity in crude cytoplasmic extracts was measured and found to be approximately 2- to 3-fold higher in the CDDP resistant cells. The isoelectric point of the glutathione transferase isozyme was 4.8 in both the sensitive and resistant cell lines, suggesting induction of the predominant isozyme present in the parent cell line. By alkaline elution there was greater cross-link formation by CDDP in the SCC-25 cell line than in the SCC-25/CP cell line at the same drug concentrations. In conclusion, the mechanism of resistance of the SCC-25/CP cell line to CDDP is multifactorial, involving plasma membrane changes, increased cytosolic binding, and decreased DNA cross-linking.

¹ This work is supported by National Cancer Institute grants 1RO1-CA36508, 1PO1-CA38493, and 5F32-CA07821.

² To whom requests for reprints should be addressed.

Received 5/19/86. Revised 9/12/86. Accepted 10/14/86.

This article has been cited by other articles:

				S. Kano, N. Miyajima, S. Fukuda, and S. Hatakeyama Tripartite Motif Protein 32 Facilitates Cell Growth and Migration via Degradation of Abl-Interactor 2 Cancer Res., July 15, 2008; 68(14): 5572 - 5580. [Abstract] [Full Text] [PDF]

				F. Nagashima, N. Boku, A. Ohtsu, S. Yoshida, T. Hasebe, A. Ochiai, Y. Sakata, H. Saito, Y. Miyata, I. Hyodo, et al. Biological Markers as a Predictor for Response and Prognosis of Unresectable Gastric Cancer Patients Treated with Irinotecan and Cisplatin Jpn. J. Clin. Oncol., December 1, 2005; 35(12): 714 - 719. [Abstract] [Full Text] [PDF]

				L. S. Rosen, B. Laxa, L. Boulos, L. Wiggins, J. G. Keck, A. J. Jameson, R. Parra, K. Patel, and G. L. Brown Phase 1 Study of TLK286 (Telcyta) Administered Weekly in Advanced Malignancies Clin. Cancer Res., June 1, 2004; 10(11): 3689 - 3698. [Abstract] [Full Text] [PDF]

				A. Bennaceur-Griscelli, J. Bosq, S. Koscielny, F. Lefrere, A. Turhan, N. Brousse, O. Hermine, and V. Ribrag High Level of Glutathione-S-Transferase {pi} Expression in Mantle Cell Lymphomas Clin. Cancer Res., May 1, 2004; 10(9): 3029 - 3034. [Abstract] [Full Text] [PDF]

				L. S. Rosen, J. Brown, B. Laxa, L. Boulos, L. Reiswig, W. D. Henner, R. T. Lum, S. R. Schow, C. A. Maack, J. G. Keck, et al. Phase I Study of TLK286 (Glutathione S-Transferase P1-1 Activated Glutathione Analogue) in Advanced Refractory Solid Malignancies Clin. Cancer Res., May 1, 2003; 9(5): 1628 - 1638. [Abstract] [Full Text] [PDF]

				G. J. Gordon, K. Appasani, J. P. Parcells, N. K. Mukhopadhyay, M. T. Jaklitsch, W. G. Richards, D. J. Sugarbaker, and R. Bueno Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma Carcinogenesis, June 1, 2002; 23(6): 1017 - 1024. [Abstract] [Full Text] [PDF]

				S. Hironaka, T. Hasebe, T. Kamijo, A. Ohtsu, N. Boku, S. Yoshida, H. Saitoh, and A. Ochiai Biopsy Specimen Microvessel Density Is a Useful Prognostic Marker in Patients with T2-4M0 Esophageal Cancer Treated with Chemoradiotherapy Clin. Cancer Res., January 1, 2002; 8(1): 124 - 130. [Abstract] [Full Text] [PDF]

				H. Kojima, K. Endo, H. Moriyama, Y. Tanaka, E. S. Alnemri, C. A. Slapak, B. Teicher, D. Kufe, and R. Datta Abrogation of Mitochondrial Cytochrome c Release and Caspase-3 Activation in Acquired Multidrug Resistance J. Biol. Chem., July 3, 1998; 273(27): 16647 - 16650. [Abstract] [Full Text] [PDF]

				B. Teicher, T. Herman, S. Holden, Y. Wang, M. Pfeffer, J. Crawford, and E Frei 3rd Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo Science, March 23, 1990; 247(4949): 1457 - 1461. [Abstract] [PDF]

				S. Kelley, A Basu, B. Teicher, M. Hacker, D. Hamer, and J. Lazo Overexpression of metallothionein confers resistance to anticancer drugs Science, September 30, 1988; 241(4874): 1813 - 1815. [Abstract] [PDF]